Regadenoson is safe, effective for use in heart transplant patients, study finds
Sunday, March 14, 2010 - 15:21
in Health & Medicine
The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a new study. Researchers say the 25 patients in the study did not experience adverse side effects such as abnormally low blood pressure or slow heart beat when regadenoson was used during the stress test.
